Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TARDIS: Intensive vs Guideline Antiplatelet Therapy in Stroke/TIA
NCT01661322Phase 3Terminated
- Sponsor
- University of Nottingham
- Start
- Apr 2009
- Primary completion
- Sep 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin, dipyridamole, clopidogrel in ischemic stroke, transient ischaemic attack (TIA), sponsored by University of Nottingham. Started Apr 2009; status: terminated.
02
Drugs
aspirindipyridamoleclopidogrel
03
Conditions
ischemic stroketransient ischaemic attack (TIA)
Beyond the preview
Go deeper on NCT01661322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01661322.